Home Tags Ketamine
The boys trapped in a Thai cave were drugged with ketamine to stop them from panicking during their terrifying rescue
Rescue divers were taught how to administer the drug, and re-sedate the boys throughout the dangerous crossing.
Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential
A drug inspired by ketamine just became the first new type of depression drug in 35 years. The FDA approved the nasal spray made by Johnson & Johnson.
A depression drug that’s been called ‘the most important discovery in half a century’ just got a big step closer to FDA approval
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.
A ‘party drug’ with potential to be the next blockbuster antidepressant is edging closer to the mainstream, but it could set you back $9,0...
Once dismissed as a "party drug," ketamine is emerging as a potential alternative treatment for depression.
Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called ‘the most important discovery in h...
A new Stanford study is the first to illuminate how ketamine works in the brain to alleviate depression. The research suggests that the drug engages the opioid system — the same one that's activated by opioid painkillers — in addition to affecting the glutamate system.
After 35 years of mediocre depression drugs, pharmaceutical companies are jazzed about several new drugs inspired by the club drug ketamine. Allergan, the multinational drugmaker known for Botox, recently dove into research on an injectable depression drug. Now they're going after an oral pill.
Psychedelic drugs appear to fundamentally reorganize the brain — and they’re starting to turn into approved treatments
From magic mushrooms to ketamine, the drugs are being tested for their potential to treat an array of diseases and conditions that currently lack adequate treatments.
A depression drug that researchers have called ‘the most important discovery in half a century’ just got a big lift
Johnson & Johnson plans to file for FDA approval of a nasal formula of ketamine for depression this year. A new study presented on Saturday suggest the drug, called esketamine, is linked with some very positive results, especially in people with the hardest to treat forms of depression.
Johnson & Johnson is actively pursuing a nasal formulation of a ketamine drug for depression. Studies so far suggest it's linked with promising results.
A new study out of Columbia University Medical Center found that ketamine was better at curbing suicidal thoughts in depressed patients than a sedative.